Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases (original) (raw)

• Schmidt, A. M. et al. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987– 14997 (1992).
  CAS PubMed Google Scholar
• Neeper, M. et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998–15004 (1992).
  CAS PubMed Google Scholar
• Hori, O. et al. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752–25761 ( 1995).
  Article CAS Google Scholar
• Wautier, J.-L et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability. J. Clin. Invest. 97, 238– 243 (1996).
  Article CAS Google Scholar
• Park, L. et al. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nature Med. 4,1025–1031 (1998).
• Yan, S. D. et al. RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685–691 (1996).
  Article ADS CAS Google Scholar
• Yan, S. D. et al. Amyloid-beta peptide-RAGE interaction elicits neuronal expression of M-CSF: a proinflammatory pathway in Alzheimer's disease. Proc. Natl Acad. Sci. USA 94, 5296–5301 (1997).
  Article ADS CAS Google Scholar
• Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889–901 (1999).
  Article CAS Google Scholar
• Yan, S.-D. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J. Biol. Chem. 269, 9889–9897 (1994).
  CAS PubMed Google Scholar
• Lander, H. L., Tauras, J. M., Ogiste, J. S., Moss, R. A. & Schmidt, A. M. Activation of the receptor for advanced glycation endproducts triggers a MAP kinase pathway regulated by oxidant stress. J. Biol. Chem. 272, 17810 –17814 (1997).
  Article CAS Google Scholar
• Huttunen, H. J., Fages, C. & Rauvala, H. Receptor for advanced glycation endproducts (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919–19924 (1999).
  Article CAS Google Scholar
• Rauvala, H. & Pihlaskari, R. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262,16625–16635 (1987).
• Rauvala, H. et al. The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J. Cell. Biol. 107, 2293–22305 (1988).
  Article CAS Google Scholar
• Parkkinen, J. & Rauvala, H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. J. Biol. Chem. 266, 16730–16735 ( 1991).
  CAS PubMed Google Scholar
• Parkkinen, J. et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem. 268,19726–19738 (1993).
• Brunet, A. et al. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664– 674 (1999).
  Article CAS Google Scholar
• Tsang, D. K. & Crowe, D. L. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int. J. Oncol. 15, 519– 523 (1999).
  CAS PubMed Google Scholar
• Talarmin, H. et al. The mitogen-activated protein kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol. Cell. Biol. 19, 6003–6011 ( 1999).
  Article CAS Google Scholar
• Klemke, R. L. et al. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137, 481– 492 (1997).
  Article CAS Google Scholar
• Montesano, R., Soriano, J. V., Hossseini, G., Pepper, M. S. & Schramek, H. Constitutively active mitogen-activated protein kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. Cell Growth Differ. 10, 317–332 ( 1999).
  CAS PubMed Google Scholar
• Reddy, K. B., Krueger, J. S., Kondapaka, S. B. & Diglio, C. A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int. J. Cancer 82, 268–273 (1999).
  Article CAS Google Scholar
• Aguirre-Ghiso, J. A. et al. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene 18, 4718– 4725 (1999).
  Article CAS Google Scholar
• Esparza, J. et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through Ras/MAP kinase signaling pathways. Blood 94, 2754– 2766 (1999).
  CAS PubMed Google Scholar
• Brett, J. et al. Tissue distribution of the receptor for advanced glycation endproducts (RAGE): expression in smooth muscle, cardiac myocytes, and neural tissue in addition to the vasculature. Am. J. Pathol. 143,1699–1712 (1993).
• O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328 (1994).
  Article CAS Google Scholar
• Leder, A., Kuo, A., Cardiff, R. D., Sinn, E. & Leder, P. V-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl Acad. Sci. USA 87, 9178–9182 ( 1990).
  Article ADS CAS Google Scholar
• Yu, W., Kim, J. & Ossowski, L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J. Cell Biol. 137, 767–777 (1997).
  Article CAS Google Scholar
• Valente, P. et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246–253 (1998).
  Article CAS Google Scholar
• Albini, A. et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239–3245 (1987).
  CAS PubMed Google Scholar
• Ramamurthy, N. S. & Golub, L. M. Diabetes increases collagenase activity in extracts of rat gingiva and skin. J. Periodont. Res. 18, 23–30 ( 1983).
  Article CAS Google Scholar